Analystreport

Takeda Pharmaceutical Company Limited (NYSE: TAK) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK)